Transgene Biotek submits copy of revised financial result

18 Apr 2016 Evaluate

Transgene Biotek has submitted a copy of Revised Financial Results (Segment Results) for the period ended December 31, 2015.

The above information is a part of company’s filings submitted to BSE.

Transgene Biotek Share Price

7.07 0.14 (2.02%)
01-Nov-2024 18:59 View Price Chart
Peers
Company Name CMP
Apollo Hospital Ent. 7036.65
Max Healthcare Inst 1006.75
Narayana Hrudayalay 1249.35
Aster DM Healthcare 444.55
Global Health 1115.50
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.